Basic clinical features do not predict dopamine transporter binding in idiopathic REM behavior disorder.


Journal

NPJ Parkinson's disease
ISSN: 2373-8057
Titre abrégé: NPJ Parkinsons Dis
Pays: United States
ID NLM: 101675390

Informations de publication

Date de publication:
2019
Historique:
received: 06 07 2018
accepted: 03 12 2018
entrez: 1 2 2019
pubmed: 1 2 2019
medline: 1 2 2019
Statut: epublish

Résumé

REM sleep behavior disorder (RBD) is strongly associated with development of Parkinson's Disease and other α-synuclein-related disorders. Dopamine transporter (DAT) binding deficit predicts conversion to α-synuclein-related disorders in individuals with RBD. In turn, identifying which individuals with RBD have the highest likelihood of having abnormal DAT binding would be useful. The objective of this analysis was to examine if there are basic clinical predictors of DAT deficit in RBD. Participants referred for inclusion in the RBD cohort of the Parkinson Progression Markers Initiative were included. Assessments at the screening visit including DAT SPECT imaging, physical examination, cognitive function screen, and questionnaire-based non-motor assessment. The group with DAT binding deficit (

Identifiants

pubmed: 30701189
doi: 10.1038/s41531-018-0073-1
pii: 73
pmc: PMC6351563
doi:

Types de publication

Journal Article

Langues

eng

Pagination

2

Investigateurs

B Kumar (B)
L James (L)
G Nomikos (G)
J Cedarbaum (J)
M Yang (M)
M Brys (M)
V Irzhevesky (V)
K Schmidt (K)
N Jennings (N)
A Reith (A)
D Tattersall (D)
M Sanchez (M)
N Daegele (N)
C Min (C)
R Malkani (R)
J Peterschmitt (J)
P Sardi (P)
S Bozzi (S)
T Fischer (T)
R Evans (R)
V Kiyasova (V)
A Simen (A)
A Siderowf (A)

Déclaration de conflit d'intérêts

The authors declare no competing interests.

Références

Am J Geriatr Psychiatry. 2002 Jan-Feb;10(1):36-43
pubmed: 11790633
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
Neurology. 2005 Nov 8;65(9):1442-6
pubmed: 16275833
Mov Disord. 2010;25 Suppl 1:S89-93
pubmed: 20187248
Ann Neurol. 2011 May;69(5):811-8
pubmed: 21246603
Prog Neurobiol. 2011 Dec;95(4):629-35
pubmed: 21930184
Brain. 2012 Jun;135(Pt 6):1860-70
pubmed: 22561644
Sleep Med. 2013 Aug;14(8):729-33
pubmed: 23245755
Mov Disord. 2013 May;28(5):597-604
pubmed: 23554107
PLoS One. 2014 Feb 26;9(2):e89741
pubmed: 24587002
Neurology. 2014 Nov 4;83(19):1739-46
pubmed: 25298306
Mov Disord. 2015 Oct;30(12):1600-11
pubmed: 26474317
JAMA Neurol. 2017 Aug 1;74(8):933-940
pubmed: 28595287
Ann Neurol. 2017 Sep;82(3):419-428
pubmed: 28833467
Ann Clin Transl Neurol. 2018 Oct 31;5(12):1460-1477
pubmed: 30564614
J Nucl Med. 1995 Jul;36(7):1175-81
pubmed: 7790941

Auteurs

L M Chahine (LM)

1Department of Neurology, The University of Pittsburgh, Pittsburgh, PA USA.

A Iranzo (A)

Neurology Service, Hospital Clinic de Barcelona, IDIBAPS, CIBERNED, Barcelona, Spain.

A Fernández-Arcos (A)

Neurology Service, Hospital Clinic de Barcelona, IDIBAPS, CIBERNED, Barcelona, Spain.

T Simuni (T)

3Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL USA.

N Seedorff (N)

4Department of Biostatistics, The University of Iowa, Iowa City, IA USA.

C Caspell-Garcia (C)

4Department of Biostatistics, The University of Iowa, Iowa City, IA USA.

A W Amara (AW)

5Department of Neurology, The University of Alabama at Birmingham, Birmingham, AL USA.

C Comella (C)

6Department of Neurology, Rush University, Chicago, IL USA.

B Högl (B)

7Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.

J Hamilton (J)

8The Michael J. Fox Foundation for Parkinson's Research, New York, NY USA.

K Marek (K)

9Institute for Neurodegenerative Disorders, New Haven, CT USA.

G Mayer (G)

Department of Neurology, Hephata-Klinik, Hephata Hessisches Diakoniezentrum, e.V, Weibersbrunn, Germany.

B Mollenhauer (B)

11Department of Neurology, University Medical Center, Göttingen, Germany.
12Paracelsus-Elena-Klinik, Kassel, Germany.

R Postuma (R)

13Division of Neurology, McGill University, Montreal, QC Canada.

E Tolosa (E)

Neurology Service, Hospital Clinic de Barcelona, IDIBAPS, CIBERNED, Barcelona, Spain.

C Trenkwalder (C)

11Department of Neurology, University Medical Center, Göttingen, Germany.
12Paracelsus-Elena-Klinik, Kassel, Germany.

A Videnovic (A)

14Department of Neurology, Massachusetts General Hospital, Boston, MA USA.

W Oertel (W)

15Department of Neurology, Philipps University, Marburg, Germany.
16Charitable Hertie Foundation, Frankfurt/Main, Germany.

Classifications MeSH